 | • レポートコード：D005-10997 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ナノ医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナノ医薬品の種類別市場規模（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルション、ナノ懸濁液、その他）、用途別市場規模（がん・腫瘍、自己免疫疾患、炎症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）： ・地域別グローバル市場分析 2015年-2020年 ・ナノ医薬品の北米市場（アメリカ、カナダ、メキシコ） ・ナノ医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ナノ医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ナノ医薬品の南米市場（ブラジル、アルゼンチン） ・ナノ医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルションおよびナノエマルション、ナノ懸濁液、その他 ・用途別分析：がん・腫瘍、自己免疫疾患、炎症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Summary
Market Overview
The global Nanopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 39510 million by 2025, from USD 24720 million in 2019.
The Nanopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nanopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nanopharmaceuticals market has been segmented into Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion and Nnanoemulsion, Nanosuspension, etc.
By Application, Nanopharmaceuticals has been segmented into Cancer and Tumor, Autoimmune Disorders, Inflammation, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Nanopharmaceuticals market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Nanopharmaceuticals markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Nanopharmaceuticals Market Share Analysis
Nanopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Nanopharmaceuticals are: Merck, Eli Lilly, Abbott, Pfizer, Sanofi, Novartis, Johnson & Johnson, Roche, GlaxoSmithKline, Astrazeneca, OSI Pharmaceuticals, Mitsubishi Pharma, Celgene, Selecta Biosciences, Kadmon Pharmaceuticals, Gilead Sciences, Novavax, Kaken Pharmaceutical, Samyang Biopharm, Stryker, Par Pharmaceutical, Lummy, Cerulean Pharma, Navidea Biopharmaceuticals, etc. Among other players domestic and global, Nanopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nanopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nanopharmaceuticals, with price, sales, revenue and global market share of Nanopharmaceuticals in 2018 and 2019.
Chapter 3, the Nanopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nanopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nanopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nanopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nanopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nanopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Market Analysis by Application
1.3.1 Overview: Global Nanopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Overview of Global Nanopharmaceuticals Market
1.4.1 Global Nanopharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astrazeneca
2.10.1 Astrazeneca Details
2.10.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astrazeneca SWOT Analysis
2.10.4 Astrazeneca Product and Services
2.10.5 Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 OSI Pharmaceuticals
2.11.1 OSI Pharmaceuticals Details
2.11.2 OSI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 OSI Pharmaceuticals SWOT Analysis
2.11.4 OSI Pharmaceuticals Product and Services
2.11.5 OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mitsubishi Pharma
2.12.1 Mitsubishi Pharma Details
2.12.2 Mitsubishi Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mitsubishi Pharma SWOT Analysis
2.12.4 Mitsubishi Pharma Product and Services
2.12.5 Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Celgene SWOT Analysis
2.13.4 Celgene Product and Services
2.13.5 Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Selecta Biosciences
2.14.1 Selecta Biosciences Details
2.14.2 Selecta Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Selecta Biosciences SWOT Analysis
2.14.4 Selecta Biosciences Product and Services
2.14.5 Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kadmon Pharmaceuticals
2.15.1 Kadmon Pharmaceuticals Details
2.15.2 Kadmon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Kadmon Pharmaceuticals SWOT Analysis
2.15.4 Kadmon Pharmaceuticals Product and Services
2.15.5 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gilead Sciences
2.16.1 Gilead Sciences Details
2.16.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gilead Sciences SWOT Analysis
2.16.4 Gilead Sciences Product and Services
2.16.5 Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Novavax
2.17.1 Novavax Details
2.17.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Novavax SWOT Analysis
2.17.4 Novavax Product and Services
2.17.5 Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Kaken Pharmaceutical
2.18.1 Kaken Pharmaceutical Details
2.18.2 Kaken Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Kaken Pharmaceutical SWOT Analysis
2.18.4 Kaken Pharmaceutical Product and Services
2.18.5 Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Samyang Biopharm
2.19.1 Samyang Biopharm Details
2.19.2 Samyang Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Samyang Biopharm SWOT Analysis
2.19.4 Samyang Biopharm Product and Services
2.19.5 Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Stryker
2.20.1 Stryker Details
2.20.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Stryker SWOT Analysis
2.20.4 Stryker Product and Services
2.20.5 Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Par Pharmaceutical
2.21.1 Par Pharmaceutical Details
2.21.2 Par Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Par Pharmaceutical SWOT Analysis
2.21.4 Par Pharmaceutical Product and Services
2.21.5 Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 Lummy
2.22.1 Lummy Details
2.22.2 Lummy Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Lummy SWOT Analysis
2.22.4 Lummy Product and Services
2.22.5 Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.23 Cerulean Pharma
2.23.1 Cerulean Pharma Details
2.23.2 Cerulean Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Cerulean Pharma SWOT Analysis
2.23.4 Cerulean Pharma Product and Services
2.23.5 Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.24 Navidea Biopharmaceuticals
2.24.1 Navidea Biopharmaceuticals Details
2.24.2 Navidea Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Navidea Biopharmaceuticals SWOT Analysis
2.24.4 Navidea Biopharmaceuticals Product and Services
2.24.5 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nanopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nanopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nanopharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Nanopharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nanopharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Nanopharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nanopharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nanopharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Nanopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nanopharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nanopharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nanopharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nanopharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nanopharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nanopharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nanopharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nanopharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nanopharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Nanopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nanopharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Nanopharmaceuticals Price by Type (2015-2020)
11 Global Nanopharmaceuticals Market Segment by Application
11.1 Global Nanopharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Nanopharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Nanopharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nanopharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Nanopharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Nanopharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Nanopharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nanopharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Nanopharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nanopharmaceuticals Market Forecast (2021-2025)
12.3 Nanopharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Nanopharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Nanopharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Nanopharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Nanopharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Nanopharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nanopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Nanopharmaceuticals Major Business
Table 9. Merck Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Nanopharmaceuticals Product and Services
Table 12. Merck Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Nanopharmaceuticals Major Business
Table 15. Eli Lilly Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Nanopharmaceuticals Product and Services
Table 18. Eli Lilly Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Abbott Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Nanopharmaceuticals Major Business
Table 21. Abbott Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 22. Abbott SWOT Analysis
Table 23. Abbott Nanopharmaceuticals Product and Services
Table 24. Abbott Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Nanopharmaceuticals Major Business
Table 27. Pfizer Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Nanopharmaceuticals Product and Services
Table 30. Pfizer Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Nanopharmaceuticals Major Business
Table 33. Sanofi Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Nanopharmaceuticals Product and Services
Table 36. Sanofi Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Nanopharmaceuticals Major Business
Table 39. Novartis Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Nanopharmaceuticals Product and Services
Table 42. Novartis Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Nanopharmaceuticals Major Business
Table 45. Johnson & Johnson Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 46. Johnson & Johnson SWOT Analysis
Table 47. Johnson & Johnson Nanopharmaceuticals Product and Services
Table 48. Johnson & Johnson Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Roche Basic Information, Manufacturing Base and Competitors
Table 50. Roche Nanopharmaceuticals Major Business
Table 51. Roche Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 52. Roche SWOT Analysis
Table 53. Roche Nanopharmaceuticals Product and Services
Table 54. Roche Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Nanopharmaceuticals Major Business
Table 57. GlaxoSmithKline Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 58. GlaxoSmithKline SWOT Analysis
Table 59. GlaxoSmithKline Nanopharmaceuticals Product and Services
Table 60. GlaxoSmithKline Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 62. Astrazeneca Nanopharmaceuticals Major Business
Table 63. Astrazeneca Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 64. Astrazeneca SWOT Analysis
Table 65. Astrazeneca Nanopharmaceuticals Product and Services
Table 66. Astrazeneca Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. OSI Pharmaceuticals Nanopharmaceuticals Major Business
Table 69. OSI Pharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 70. OSI Pharmaceuticals SWOT Analysis
Table 71. OSI Pharmaceuticals Nanopharmaceuticals Product and Services
Table 72. OSI Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Pharma Nanopharmaceuticals Major Business
Table 75. Mitsubishi Pharma Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 76. Mitsubishi Pharma SWOT Analysis
Table 77. Mitsubishi Pharma Nanopharmaceuticals Product and Services
Table 78. Mitsubishi Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Celgene Basic Information, Manufacturing Base and Competitors
Table 80. Celgene Nanopharmaceuticals Major Business
Table 81. Celgene Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 82. Celgene SWOT Analysis
Table 83. Celgene Nanopharmaceuticals Product and Services
Table 84. Celgene Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
Table 86. Selecta Biosciences Nanopharmaceuticals Major Business
Table 87. Selecta Biosciences Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 88. Selecta Biosciences SWOT Analysis
Table 89. Selecta Biosciences Nanopharmaceuticals Product and Services
Table 90. Selecta Biosciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Kadmon Pharmaceuticals Nanopharmaceuticals Major Business
Table 93. Kadmon Pharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 94. Kadmon Pharmaceuticals SWOT Analysis
Table 95. Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services
Table 96. Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 98. Gilead Sciences Nanopharmaceuticals Major Business
Table 99. Gilead Sciences Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 100. Gilead Sciences SWOT Analysis
Table 101. Gilead Sciences Nanopharmaceuticals Product and Services
Table 102. Gilead Sciences Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Novavax Basic Information, Manufacturing Base and Competitors
Table 104. Novavax Nanopharmaceuticals Major Business
Table 105. Novavax Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 106. Novavax SWOT Analysis
Table 107. Novavax Nanopharmaceuticals Product and Services
Table 108. Novavax Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Kaken Pharmaceutical Nanopharmaceuticals Type and Application
Table 110. Kaken Pharmaceutical Nanopharmaceuticals Major Business
Table 111. Kaken Pharmaceutical Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 112. Kaken Pharmaceutical SWOT Analysis
Table 113. Kaken Pharmaceutical Nanopharmaceuticals Product and Services
Table 114. Kaken Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
Table 116. Samyang Biopharm Nanopharmaceuticals Major Business
Table 117. Samyang Biopharm Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 118. Samyang Biopharm SWOT Analysis
Table 119. Samyang Biopharm Nanopharmaceuticals Product and Services
Table 120. Samyang Biopharm Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Stryker Basic Information, Manufacturing Base and Competitors
Table 122. Stryker Nanopharmaceuticals Major Business
Table 123. Stryker Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 124. Stryker SWOT Analysis
Table 125. Stryker Nanopharmaceuticals Product and Services
Table 126. Stryker Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Par Pharmaceutical Nanopharmaceuticals Major Business
Table 129. Par Pharmaceutical Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 130. Par Pharmaceutical SWOT Analysis
Table 131. Par Pharmaceutical Nanopharmaceuticals Product and Services
Table 132. Par Pharmaceutical Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Lummy Basic Information, Manufacturing Base and Competitors
Table 134. Lummy Nanopharmaceuticals Major Business
Table 135. Lummy Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 136. Lummy SWOT Analysis
Table 137. Lummy Nanopharmaceuticals Product and Services
Table 138. Lummy Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Cerulean Pharma Nanopharmaceuticals Major Business
Table 141. Cerulean Pharma Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 142. Cerulean Pharma SWOT Analysis
Table 143. Cerulean Pharma Nanopharmaceuticals Product and Services
Table 144. Cerulean Pharma Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 145. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Navidea Biopharmaceuticals Nanopharmaceuticals Major Business
Table 147. Navidea Biopharmaceuticals Nanopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 148. Navidea Biopharmaceuticals SWOT Analysis
Table 149. Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services
Table 150. Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 151. Global Nanopharmaceuticals Sales by Manufacturer (2018-2019) (K MT)
Table 152. Global Nanopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 153. Global Nanopharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 154. Global Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 155. Global Nanopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 156. North America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 157. North America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 158. North America Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 159. North America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 160. Europe Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 161. Europe Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 162. Europe Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 163. Asia-Pacific Nanopharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 164. Asia-Pacific Nanopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 165. Asia-Pacific Nanopharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 166. South America Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 167. South America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 168. South America Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 169. South America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 170. Middle East & Africa Nanopharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 171. Middle East & Africa Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Table 172. Middle East & Africa Nanopharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 173. Middle East & Africa Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 174. Global Nanopharmaceuticals Sales by Type (2015-2020) (K MT)
Table 175. Global Nanopharmaceuticals Sales Share by Type (2015-2020)
Table 176. Global Nanopharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 177. Global Nanopharmaceuticals Revenue Share by Type (2015-2020)
Table 178. Global Nanopharmaceuticals Sales by Application (2015-2020) (K MT)
Table 179. Global Nanopharmaceuticals Sales Share by Application (2015-2020)
Table 180. Global Nanopharmaceuticals Sales Forecast by Regions (2021-2025) (K MT)
Table 181. Global Nanopharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 182. Global Nanopharmaceuticals Sales Forecast by Type (2021-2025) (K MT)
Table 183. Global Nanopharmaceuticals Market Share Forecast by Type (2021-2025)
Table 184. Global Nanopharmaceuticals Sales Forecast by Application (2021-2025)
Table 185. Global Nanopharmaceuticals Market Share Forecast by Application (2021-2025)
Table 186. Direct Channel Pros & Cons
Table 187. Indirect Channel Pros & Cons
Table 188. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nanopharmaceuticals Picture
Figure 2. Global Sales Market Share of Nanopharmaceuticals by Type in 2019
Figure 3. Liposomes Picture
Figure 4. Polymeric Micelles Picture
Figure 5. Solid Lipid Nanoparticles Picture
Figure 6. Microemulsion and Nnanoemulsion Picture
Figure 7. Nanosuspension Picture
Figure 8. Nanopharmaceuticals Sales Market Share by Application in 2018
Figure 9. Cancer and Tumor Picture
Figure 10. Autoimmune Disorders Picture
Figure 11. Inflammation Picture
Figure 12. Others Picture
Figure 13. Global Nanopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Nanopharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Nanopharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 34. Global Nanopharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Nanopharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Nanopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 41. Global Nanopharmaceuticals Revenue Market Share by Regions in 2018
Figure 42. North America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. Europe Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 45. South America Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020)
Figure 47. North America Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Nanopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 49. North America Nanopharmaceuticals Sales Market Share by Countries in 2018
Figure 50. North America Nanopharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Nanopharmaceuticals Revenue Market Share by Countries in 2018
Figure 52. United States Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 58. Germany Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Nanopharmaceuticals Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Nanopharmaceuticals Revenue Market Share by Regions 2019
Figure 66. China Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Nanopharmaceuticals Sales Market Share by Countries in 2019
Figure 73. South America Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 74. Brazil Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Nanopharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Nanopharmaceuticals Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Nanopharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Nanopharmaceuticals Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Nanopharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Nanopharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
リポソームの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liposomes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liposomes market report provides a …- 磁性ナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Magnetic Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Magnetic Nanoparticles…
- 酸化セリウムナノ粒子の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cerium Oxide Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.5% in the forecast period of 2020 to 2025 and will expected to reach USD 448.4 million by 2025, from USD 300.5 million in 2019. The Cerium Oxi…
- 高分子接着剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Polymeric Adhesive market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polymeric Adhesive market …
- 細胞外高分子物質の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Extracellular Polymeric Substances market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Extracellu…